2022
DOI: 10.1016/j.biocel.2022.106326
|View full text |Cite
|
Sign up to set email alerts
|

Function of connexin 43 and RhoA/LIMK2/Cofilin signaling pathway in transient changes of contraction and dilation of human umbilical arterial smooth muscle cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(6 citation statements)
references
References 43 publications
0
6
0
Order By: Relevance
“…Cells were serum-starved for 24 h in DMEM before drug treatment, to switch the cell phenotype from proliferating to contractile [ 29 ]. Treatment with 1 μM Ang II for 12 h has been found to significantly promote VSMC proliferation and migration, which are indicators of vascular remodeling and are thought to be the main causes of hypertension [ 30 ]; hence, 1 μM Ang II (G-CLONE, Beijing, China) was administered to HUASMCs for 12 h. In accordance with an earlier study [ 15 ], we pretreated cells with 30 μM propofol (Kelun, Sichuang, China) to explore the changes in VSMCs in patients with hypertension and with propofol administration at the early stage of anesthesia induction. In addition, cells were treated with an intracellular calcium chelator (BAPTA-AM, 10 μM, APExBIO, Houston, USA), the specific Cx43 gap junction agonist retinoic acid (RA, 1 μM, MedChemExpress, New Jersey, USA) [ 31 ], a specific Cx43 gap junction blocker (Gap26, 0.25 mg/ml, APExBIO, Houston, USA), and a selective RhoA inhibitor (50 μM, Rhosin hydrochloride, APExBIO).…”
Section: Methodsmentioning
confidence: 67%
See 4 more Smart Citations
“…Cells were serum-starved for 24 h in DMEM before drug treatment, to switch the cell phenotype from proliferating to contractile [ 29 ]. Treatment with 1 μM Ang II for 12 h has been found to significantly promote VSMC proliferation and migration, which are indicators of vascular remodeling and are thought to be the main causes of hypertension [ 30 ]; hence, 1 μM Ang II (G-CLONE, Beijing, China) was administered to HUASMCs for 12 h. In accordance with an earlier study [ 15 ], we pretreated cells with 30 μM propofol (Kelun, Sichuang, China) to explore the changes in VSMCs in patients with hypertension and with propofol administration at the early stage of anesthesia induction. In addition, cells were treated with an intracellular calcium chelator (BAPTA-AM, 10 μM, APExBIO, Houston, USA), the specific Cx43 gap junction agonist retinoic acid (RA, 1 μM, MedChemExpress, New Jersey, USA) [ 31 ], a specific Cx43 gap junction blocker (Gap26, 0.25 mg/ml, APExBIO, Houston, USA), and a selective RhoA inhibitor (50 μM, Rhosin hydrochloride, APExBIO).…”
Section: Methodsmentioning
confidence: 67%
“…As reported, both the RhoA/LIMK2/cofolin and RhoA/MLCK pathways can lead to cell contraction [ 15 , 24 ]. Our results demonstrated that Ang II exposure significantly activated the RhoA/LIMK2/cofilin and RhoA/MLCK signaling pathways, manifested as an increase in key molecules, such as p-LIMK2, p-cofilin and MLCK, which was reversed by propofol and Rhosin (Fig.…”
Section: Resultsmentioning
confidence: 94%
See 3 more Smart Citations